Pure Midwest

CBD News Aggregator

FDA pledges action against ‘unlawful CBD products’ while offering confidentiality for research

The U.S. Food and Drug Administration said it will continue to “take appropriate action against unlawful CBD products that pose a risk of harm to the public,” even as the federal agency implored the industry to collaborate with the government to study CBD’s possible benefits and dangers.

The statement Thursday from new FDA Commissioner Dr. Stephen Hahn did not mention a timeline for when the agency will release CBD-usage guidelines, which businesses have been expecting for several months.

But there were some new positions staked out in the memo issued in response to pressure from Congress to issue regulations allowing the sale of hemp-derived CBD without a doctor’s prescription.

Leave a Reply

woocommerce social proof plugin
%d bloggers like this: